Monatepil maleate
CAS No. 103379-03-9
Monatepil maleate ( —— )
产品货号. M34105 CAS No. 103379-03-9
Monatepil maleate (AJ-2615 maleate) is an orally active Ca2+-channel and α1-adrenoceptor antagonist and non-competitive heparanoyl-coenzyme A:cholesterol acyltransferase (ACAT) inhibitor with antihypertensive activity. Monatepil maleate is used in studies of hyperlipidemia and atherosclerosis. Monatepil maleate is used to study hyperlipidemia and atherosclerosis.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥3786 | 有现货 |
|
| 5MG | ¥5830 | 有现货 |
|
| 10MG | ¥7970 | 有现货 |
|
| 25MG | ¥11886 | 有现货 |
|
| 50MG | ¥15484 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Monatepil maleate
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Monatepil maleate (AJ-2615 maleate) is an orally active Ca2+-channel and α1-adrenoceptor antagonist and non-competitive heparanoyl-coenzyme A:cholesterol acyltransferase (ACAT) inhibitor with antihypertensive activity. Monatepil maleate is used in studies of hyperlipidemia and atherosclerosis. Monatepil maleate is used to study hyperlipidemia and atherosclerosis.
-
产品描述Monatepil maleate (AJ-2615 maleate) is an orally active Ca2+-channel and α1-adrenoceptor antagonist and non-competitive heparanoyl-coenzyme A:cholesterol acyltransferase (ACAT) inhibitor with antihypertensive activity.Monatepil maleate is used in studies of hyperlipidemia and atherosclerosis. Monatepil maleate is used to study hyperlipidemia and atherosclerosis.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Acyltransferase | Calcium Channel | Adrenergic Receptor
-
研究领域——
-
适应症——
化学信息
-
CAS Number103379-03-9
-
分子量591.69
-
分子式C32H34FN3O5S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESC(=C\C(O)=O)\C(O)=O.N(C(CCCN1CCN(CC1)C2=CC=C(F)C=C2)=O)C3C=4C(CSC=5C3=CC=CC5)=CC=CC4
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
IL-1a (223-250) (hum...
IL-1a (223-250) (human)
-
Diethylaminoethoxyet...
用于生产止咳药托克酶等。
-
Ladanein
Ladanein is a phytochemicals inhibitor that is known to disrupt the interactions of core and other hepatitis C virus (HCV) proteins.Ladanein possesses free radicals DPPH and ABTS +.scavenging activity, it also displays moderate (20-40 microM) activities against K562, K562R (imatinib-resistant), and 697 human leukemia cell lines.
021-51111890
购物车()
sales@molnova.cn

